Research Archive

Blog and Market Intelligence

Public-safe BSM LLC research notes, company assessments, and strategic intelligence.

General research only. No personalized investment advice or capital-action recommendation.
Eli Lilly and the GLP-1 Platform Compounding Machine

Eli Lilly as a GLP-1 cardiometabolic platform across Mounjaro, Zepbound, orforglipron, retatrutide, manufacturing capacity, valuation, and payer pressure.

July 2026